Navigation Links
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
Date:1/28/2009

tal Sales Data. Net sales for the second quarter and first six months of fiscal 2009 increased to $14.0 and $27.4 million up from $13.1 and $24.7 million, respectively, in the prior fiscal year periods. Additional details are summarized below.

                     Three Months Ended Year over  Six Months Ended Year over
                       December 31,       Year %      December 31,   Year %
                     2008       2007     Change    2008       2007   Change
    ($millions)
    Orthopaedic
     Products        $7.1       $7.2      (2%)    $15.1      $13.4     13%
    Cardiovascular
     Products        $5.3       $3.5      48%      $9.2       $7.4     26%
    Endovascular
     Products        $0.9       $1.7     (47%)     $1.7       $3.0    (45%)
    Other Products   $0.7       $0.7       2%      $1.4       $0.9     56%
    Total Net
     Sales -        $14.0      $13.1       6%     $27.4      $24.7     11%

Guidance for Fiscal Quarter Ending March 31, 2009 (Third Quarter of Fiscal 2009)

For the third quarter of fiscal 2009, the Company currently anticipates that its net sales will be in a range of $13.5 to $14.0 million, representing a slight decrease from the comparable prior fiscal year quarter. The Company expects this decrease because of its shift from a direct sales model of the endovascular products in fiscal year 2008 to a strategic partnership resulting from the sale of the endovascular business in May 2008. Biomaterial sales are expected to be in the range of $12.7 million to $13.1 million, representing an increase of 1% to 4% from the comparable prior fiscal year quarter, and endovascular sales are expected to be approximately $900,000, representing a decrease of 42% from the comparable prior fiscal year quarter. Royalties are expected to be in the range of $6.9 to $7.1 million, representing a 7% to 10% increase from the comparable prior fiscal year quarte
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
2. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
3. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
4. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
5. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
6. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
7. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
8. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
9. GEN Reports on Growing Reliance on Microfluidics Technology
10. Novozymes Reports Strong 2008 Results
11. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014 The Alliance ... a survey of European physicians at the "1 ... and Biological Therapies" at the Spanish Ministry of ... by EuropaBio and the Spanish Bioindustry Association (ASEBIO), ... physicians from Spanish oncology and rheumatology societies, representatives ...
(Date:11/26/2014)... Winston-Salem, NC (PRWEB) November 26, 2014 ... Medical Advisory Board. PMG Research is a network of sites ... with access to over 2 million patient lives through its ... Research is comprised of 11 hub site locations in the ... , The first term of the board will ...
(Date:11/26/2014)... Silicon Valley Electronic Data Capture (EDC) provider ... , provider of clinical research and data management services ... to its CRO Partnership Program, Clinovo expands ClinCapture ... , “We have found Clinovo’s ClinCapture to exceed ... which is both user friendly and easy to deploy. ...
(Date:11/26/2014)... 2014 Global biostimulants market is ... at an estimated CAGR of 12.5%. In order ... products with least ecological impacts, farmers are looking ... boost crop yield more effectively & efficiently. Biostimulants ... improve the return on investments. , Leading companies ...
Breaking Biology Technology:ASBM Presents European Physicians Survey at Spanish Ministry of Health 2PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 32019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 4
... Netherlands, January 16 Today Top Institute,Pharma announces ... at the,development of a malaria vaccine. This TI ... from previous studies. The project aims to,develop a ... lives of,millions of people in developing countries, especially ...
... for the, Maintenance and Prophylactic Treatment of Asthma in Patients 12 ... ... ALVESCO(R) Will be Commercialised by ... Food and Drug Administration (FDA) approved ALVESCO(R),(ciclesonide) Inhalation Aerosol in the United ...
... ,Center of Excellence, Advancing Performance in ... Patient Outcomes, Costs and Convenience, COSTA MESA, Calif., ... today that it has completed the,previously announced acquisition of Neuro-Therapy ... announced,that Daniel A. Hoffman, MD has been appointed Chief Medical ...
Cached Biology Technology:Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers 2Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers 3Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers 4ALVESCO(R) Gains FDA Approval for the U.S. Market 2ALVESCO(R) Gains FDA Approval for the U.S. Market 3ALVESCO(R) Gains FDA Approval for the U.S. Market 4CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer 2CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer 3
(Date:11/6/2014)... metastasis, yet progress in preventing and treating migratory ... particularly challenging to design drugs that work against ... biology at Harvard Medical School. , "Unfortunately, ... metastasized." , Gujral and colleagues have now identified ... understand how metastasis begins. Their findings may also ...
(Date:11/5/2014)... show great diversity in their ability to identify scents ... differ in their perceptual evaluation of odors, with women ... , Sex differences in olfactory detection may play ... connected to one,s perception of smell, which is naturally ... superiority has been suggested to be cognitive or emotional, ...
(Date:11/4/2014)... study examining only marketing directed at children on ... has found that the majority of black, middle-income ... marketing tactics. , Authored by Arizona State University ... is the first to examine the use of ... fast food restaurants and its relationship to demographics. ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3The female nose always knows: Do women have more olfactory neurons? 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3
... Aug. 18 Central Florida based locksmith,and safe ... its strategic,alliance with security firm Absolute Access and ... well as all customer service,functions, will be offered ... complete with a new office and showroom location ...
... reported that children with autism have a wide range ... a simple genetic test to identify the disorder. Now, ... reveal correlations in the facial features and brain structures ... enable them to develop a formula for earlier detection ...
... five faculty planning grants to develop long-term research programs ... for fresh water. "Fresh water is crucial to ... than a billion people have no access to safe ... sanitation facilities," said Woods Institute Senior Fellow Richard Luthy, ...
Cached Biology News:Cuellar's Safe and Lock Announces Strategic Alliance with Absolute Access and Security 2Researchers study facial structures, brain abnormalities to reveal formula for detection of autism 2New planning grants to fund research on freshwater issues 2New planning grants to fund research on freshwater issues 3
... to be able to handle larger sample volumes, ... well as interface with telemetry systems. The ... with dogs, pigs, and primates. The system ... and the computer can be located outside the ...
... laboratories working in a regulated environment, ... pipette calibration software that automates gravimetric ... a framework that meets todays regulatory ... a secure solution that includes a ...
... in plasma from juvenile or male fish is ... chemicals (EDCs) with estrogenic effects in fish. Quantification ... for the estrogenic effects of EDCs in fish. ... double-antibody immunometric (sandwich) EIA for analyzing Vtg in ...
... target for which no antibody exists? Having difficulty ... for a variety of pharmaceutical, biotech and academic ... our technology and expertise in antibody generation to ... patented RabMAb development technology , High affinity and ...
Biology Products: